Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

← All Briefs

Daily Intelligence Brief

Tuesday, August 4, 2026

Suboxone Drives a Firm-Weighted Filing Surge

Suboxone Film Products Liability Litigation (3092) dominated the day’s intake with 130 filings, led by Nigh Goldenberg Raso Vaughn PLLC. Bard Implanted Port Catheter Products Liability Litigation (3081) followed with 30 complaints as Simmons Hanly Conroy LLP filed eight and Roman Balaban & Associates LLC filed five, concentrating the device docket’s next tier. Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) added 11 cases, led by Singleton Schreiber LLP’s three and Wallace Miller’s two. Platform and legacy-drug activity finished the top tier: Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) received 10 filings from Keller Postman LLC and Lieff Cabraser, while Zantac Products Liability Litigation (2924) logged seven, all from Keller Postman LLC. See the full filing feed and firm-level breakdowns here.

Semaglutide NAION Report Focuses Causation Inquiry

An August 3 online case report proposed a two-hit model for semaglutide-associated non-arteritic anterior ischemic optic neuropathy, putting anatomical susceptibility and sustained hypohydration at the center of Glucagon-like Peptide-1 Receptor Agonists Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation (3163). The report described a 28-year-old man who developed right NAION four to five months after starting semaglutide, with imaging showing bilateral buried optic disc drusen and serial measurements showing a 1.9-liter decline in total body water. The account is hypothesis-generating rather than proof of product causation, but it gives counsel a concrete alternative-causation framework as expert opinions develop. Plaintiffs will need to distinguish an alleged drug effect from claimant-specific anatomy and hydration history, while defendants will press those factors as competing explanations.

Study Cuts Against Simple Screen-Time Theory

An August 3 longitudinal publication cut against a simple screen-time theory in Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047), finding no main association between time spent on social media and internalizing problems at ages 15 or 18. Problematic social-media use, however, was consistently associated with more internalizing problems cross-sectionally and showed a small longitudinal association driven primarily by girls. The distinction gives defendants current support to challenge opinions that equate exposure time with injury, while preserving a narrower inquiry into compulsive-use evidence. Plaintiffs will need to connect platform design and each claimant’s usage pattern to the alleged mental-health harm rather than rely on raw hours online.

Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.